Clinical Trials Directory

Trials / Completed

CompletedNCT01407835

Biological Standardization of Dactylis Glomerata Allergen Extract

Biological Standardization of Dactylis Glomerata Allergen Extract to Determine the Biological Activity in Histamine Equivalent Prick (HEP) Units

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
31 (actual)
Sponsor
Laboratorios Leti, S.L. · Industry
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to determine the biologic activity of a Dactylis glomerata allergen extract in histamine equivalent prick (HEP) units, in order to be used as in-house reference preparation (IHRP).

Detailed description

This is an open, unblinded and non-randomized biological assay. The study design is a slight modification of the recommendations proposed by the Nordic Guidelines. Four concentrations of Dactylis glomerata allergen extract, together with a positive and negative control, using 10 mg/ml histamine dihydrochloride solution and a glycerinated phenol saline solution, respectively, will be tested in every patient in duplicate on the volar surface of the forearm.

Conditions

Interventions

TypeNameDescription
BIOLOGICALFour different concentrations of Dactylis glomerata allergen extract, positive control and negative controlFour concentrations of Dactylis glomerata allergen extract, together with a positive and negative control will be tested in every patient in duplicate on the volar surface of the forearm.

Timeline

Start date
2011-10-01
Primary completion
2012-03-01
Completion
2012-06-01
First posted
2011-08-02
Last updated
2012-08-09

Locations

2 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT01407835. Inclusion in this directory is not an endorsement.